X
CLMT icon

Xponance’s Calumet Specialty Products CLMT Stock Holding History

Xponance’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
7,693
+1,231
+19% +$41.4K ﹤0.01% 1446
2026
Q1 		$232K Buy
+6,462
New +$167K ﹤0.01% 1405

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Xponance's CLMT Position: Q2 2026 in Review

Xponance increased its Calumet Specialty Products (CLMT) stake by 19% in Q2 2026, buying an estimated $41.4K and bringing the position to 7,693 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

Xponance first reported a position in CLMT in Q1 2026 and has held it in 2 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Xponance held 7,693 shares of Calumet Specialty Products worth $277K as of Q2 2026.
  • Xponance bought 1,231 Calumet Specialty Products shares in Q2 2026, an estimated $41.4K.
  • Calumet Specialty Products made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1446 holding.
  • Xponance first reported a position in Calumet Specialty Products in Q1 2026 and has held it in 2 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.